Clinical trial
A Study of the Electrocardiogram Effects and Pharmacokinetics of Ferumoxytol in…
NCT00360425 · AMAG Pharmaceuticals, Inc., Industry · Completed
Key facts
| NCT number | NCT00360425 |
|---|---|
| Title | A Study of the Electrocardiogram Effects and Pharmacokinetics of Ferumoxytol in Healthy Men and Women |
| Official title | A Phase 1 Active- and Placebo-Controlled Study of the Electrocardiogram Effects and Pharmacokinetics of Ferumoxytol in Healthy Men and Women |
| Lead sponsor | AMAG Pharmaceuticals, Inc., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | ferumoxytol, moxifloxacin, placebo |
| Enrollment | 174 |
| Start date | May 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Aug 4, 2006 |
| Last update posted | Apr 4, 2022 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: